BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2675517)

  • 1. Diagnostic accuracy of the immunocytochemical study of body fluids.
    Li CY; Ziesmer SC; Wong YC; Yam LT
    Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
    Ruitenbeek T; Gouw AS; Poppema S
    Arch Pathol Lab Med; 1994 Mar; 118(3):265-9. PubMed ID: 8135629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of lymphocyte marker studies in diagnostic cytopathology.
    Robey SS; Cafferty LL; Beschorner WE; Gupta PK
    Acta Cytol; 1987; 31(4):453-9. PubMed ID: 3300124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories.
    Kendall B; Dunn C; Solanki P
    Arch Pathol Lab Med; 1997 Sep; 121(9):976-9. PubMed ID: 9302931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical identification of cells in serous effusions. Technical considerations.
    Li CY; Lazcano-Villareal O; Pierre RV; Yam LT
    Am J Clin Pathol; 1987 Dec; 88(6):696-706. PubMed ID: 2446492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of immunologic tumor markers in body fluid analysis.
    Kjeldsberg CR; Marty J
    Clin Lab Med; 1985 Jun; 5(2):233-64. PubMed ID: 3896624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Advia 120 hematology analyzer in the differential cytologic analysis of biological fluids (cerebrospinal, peritoneal, pleural, pericardial, synovial, and others).
    Aulesa C; Mainar I; Prieto M; Cobos N; Galimany R
    Lab Hematol; 2003; 9(4):214-24. PubMed ID: 14649464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study.
    van der Kwast TH; Versnel MA; Delahaye M; de Jong A; Zondervan PE; Hoogsteden H
    Acta Cytol; 1988; 32(2):169-74. PubMed ID: 3348058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
    Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
    Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytology of body fluids from different sites: an approach for early diagnosis of malignancy.
    Pradhan SB; Pradhan B; Dali S
    JNMA J Nepal Med Assoc; 2006; 45(164):353-6. PubMed ID: 17676071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemistry on fine needle aspirates in paraffin miniblocks.
    Domagala WM; Markiewski M; Tuziak T; Kram A; Weber K; Osborn M
    Acta Cytol; 1990; 34(3):291-6. PubMed ID: 2140487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspirates.
    Elequin FT; Muggia FM; Ghossein NA; Schreiber K
    Acta Cytol; 1977; 21(4):596-9. PubMed ID: 269612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological features of melanoma in exfoliative fluid specimens.
    Murali R; Loughman NT; McKenzie PR; Watson GF; Thompson JF; Scolyer RA
    J Clin Pathol; 2009 Jul; 62(7):638-43. PubMed ID: 19561232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical staining of unstained versus previously stained cytologic preparations.
    Abendroth CS; Dabbs DJ
    Acta Cytol; 1995; 39(3):379-86. PubMed ID: 7539200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial immunolabelling in the diagnosis of solid tumors undergoing cytologic studies (cytopuncture and imprints)].
    Chosia M; Gaulier A; Marsan C
    Arch Anat Cytol Pathol; 1989; 37(3):99-108. PubMed ID: 2665669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of leukocyte esterase detection and the presence of leukocytes in body fluids.
    Smalley DL; Doyle VR; Duckworth JK
    Am J Med Technol; 1982 Feb; 48(2):135-7. PubMed ID: 7064989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.